BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Guan MC, Wang MD, Liu SY, Ouyang W, Liang L, Pawlik TM, Xu QR, Huang DS, Shen F, Zhu H, Yang T. Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedside. World J Gastrointest Oncol 2021; 13(4): 197-215 [PMID: 33889272 DOI: 10.4251/wjgo.v13.i4.197]
URL: https://www.wjgnet.com/1007-9327/full/v13/i4/197.htm
Number Citing Articles
1
Chaokun Yan, Mengyuan Li, Zhihao Suo, Jun Zhang, Jianlin Wang, Ge Zhang, Wenjuan Liang, Huimin Luo. Biomarkers Identification of Hepatocellular Carcinoma Based on Multiomics Data Integration and Graph-embedded Deep Neural NetworkCurrent Bioinformatics 2023; 18(6): 459 doi: 10.2174/1574893618666230227122331
2
Andreia P Alves, Sandra M Rocha, Ana C Mamede, Patrícia C Braga, Marco G Alves, Pedro F Oliveira, Filomena M Botelho, Cláudio J Maia. Differential response of hepatocellular carcinoma glycolytic metabolism and oxidative stress markers after exposure to human amniotic membrane proteinsMolecular Biology Reports 2022; 49(8): 7731 doi: 10.1007/s11033-022-07598-5
3
Lingli Huang, Hui Xu, Tianyu Wu, Gaofeng Li, San Jun Shi. Hedyotis diffusa Willd. Suppresses Hepatocellular Carcinoma via Downregulating AKT/mTOR PathwaysEvidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/5210152
4
Ming-Cheng Guan, Shi-Yu Zhang, Qian Ding, Na Li, Ting-Ting Fu, Gui-Xia Zhang, Qian-Qian He, Feng Shen, Tian Yang, Hong Zhu. The Performance of GALAD Score for Diagnosing Hepatocellular Carcinoma in Patients with Chronic Liver Diseases: A Systematic Review and Meta-AnalysisJournal of Clinical Medicine 2023; 12(3): 949 doi: 10.3390/jcm12030949
5
Yuquan Qian, Timo Itzel, Matthias Ebert, Andreas Teufel. Deep View of HCC Gene Expression Signatures and Their Comparison with Other CancersCancers 2022; 14(17): 4322 doi: 10.3390/cancers14174322
6
Min Yao, Jian-Jun Wang, Xi-Yu Chen, Wen-Li Sai, Jie Yang, De-Feng Wang, Li Wang, Deng-Fu Yao. Oncogenic Wnt3a is a promising sensitive biomarker for monitoring hepatocarcinogenesisHepatobiliary & Pancreatic Diseases International 2023; 22(3): 263 doi: 10.1016/j.hbpd.2022.11.004
7
Ming-Da Wang, Li-Yang Sun, Guo-Jun Qian, Chao Li, Li-Hui Gu, Lan-Qing Yao, Yong-Kang Diao, Timothy M. Pawlik, Wan Yee Lau, Dong-Sheng Huang, Feng Shen, Tian Yang. Prothrombin induced by vitamin K Absence-II versus alpha-fetoprotein in detection of both resectable hepatocellular carcinoma and early recurrence after curative liver resection: A retrospective cohort studyInternational Journal of Surgery 2022; 105: 106843 doi: 10.1016/j.ijsu.2022.106843
8
Innocent Benjamin, Terkumbur E. Gber, Hitler Louis, Tabe N. Ntui, Emmanuella I. Oyo-Ita, Tomsmith O. Unimuke, Moses M. Edim, Adedapo S. Adeyinka. Modelling of Aminothiophene-Carbonitrile Derivatives as Potential Drug Candidates for Hepatitis B and CIranian Journal of Science and Technology, Transactions A: Science 2022; 46(5): 1399 doi: 10.1007/s40995-022-01355-w
9
Jianwei Wang, Xiaowen Guan, Ning Shang, Di Wu, Zihan Liu, Zhenzhen Guan, Zhizi Zhang, Zhongzhen Jin, Xiaoyi Wei, Xiaoran Liu, Mingzhu Song, Weijun Zhu, Guifu Dai. Dysfunction of CCT3-associated network signals for the critical state during progression of hepatocellular carcinomaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024; 1870(4): 167054 doi: 10.1016/j.bbadis.2024.167054
10
Ming-Cheng Guan, Wei Ouyang, Si-Yu Liu, Li-Yang Sun, Wei-Yue Chen, Xiang-Min Tong, Hong Zhu, Tian Yang. Alpha-fetoprotein, protein induced by vitamin K absence or antagonist-II, lens culinaris agglutinin-reactive fraction of alpha-fetoprotein alone and in combination for early detection of hepatocellular carcinoma from nonalcoholic fatty liver disease: A multicenter analysisHepatobiliary & Pancreatic Diseases International 2022; 21(6): 559 doi: 10.1016/j.hbpd.2022.05.003
11
Kareem A. Attallah, Mohamed S. Albannan, Khaled Farid, Sherine M. Rizk, Nevine Fathy. HCC-Check: A Novel Diagnostic Tool for Early Detection of Hepatocellular Carcinoma Based on Cytokeratin-1 and Epithelial Membrane Antigen: A Cross-Sectional StudyTechnology in Cancer Research & Treatment 2024; 23 doi: 10.1177/15330338241234790
12
Yanli Liu, Wanmei Liang, Yabin Chang, Zehui He, Meijian Wu, Haozhi Zheng, Xinrong Ke, Minjia Lv, Qingqian Liu, Qinyu Liu, Waner Tang, Qiaoling Huang, Yu Lu, Min He, Qijun Yang, Chunpan Mo, Jiefan Wang, Kunwei Peng, Zhiqun Min, Hang Su, Jingqi Chen. CEP192 is a novel prognostic marker and correlates with the immune microenvironment in hepatocellular carcinomaFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.950884